Pierre, Fabre

Pierre Fabre anuncia el primer paciente tratado en fase I/ II de PFL-002/ VERT-002

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Pierre Fabre Laboratories United States of America Canada France Germany Spain United Kingdom California

en | boerse | 67956618 |